MacroGenics, Inc. (MGNX)
4.135
+0.06
(+1.35%)
USD |
NASDAQ |
Aug 28, 16:00
4.03
-0.10
(-2.54%)
After-Hours: 17:16
MacroGenics Total Assets (Quarterly) : 345.41M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 345.41M |
| March 31, 2026 | 217.87M |
| December 31, 2025 | 264.57M |
| September 30, 2025 | 270.76M |
| June 30, 2025 | 245.42M |
| March 31, 2025 | 224.56M |
| December 31, 2024 | 270.56M |
| September 30, 2024 | 264.49M |
| June 30, 2024 | 201.14M |
| March 31, 2024 | 248.28M |
| December 31, 2023 | 306.82M |
| September 30, 2023 | 339.97M |
| June 30, 2023 | 305.65M |
| March 31, 2023 | 343.50M |
| December 31, 2022 | 289.51M |
| September 30, 2022 | 195.35M |
| June 30, 2022 | 218.04M |
| March 31, 2022 | 271.44M |
| December 31, 2021 | 335.24M |
| September 30, 2021 | 392.16M |
| June 30, 2021 | 425.91M |
| March 31, 2021 | 435.44M |
| December 31, 2020 | 378.74M |
| September 30, 2020 | 374.38M |
| June 30, 2020 | 327.59M |
| Date | Value |
|---|---|
| March 31, 2020 | 265.41M |
| December 31, 2019 | 312.50M |
| September 30, 2019 | 351.45M |
| June 30, 2019 | 383.68M |
| March 31, 2019 | 414.64M |
| December 31, 2018 | 332.13M |
| September 30, 2018 | 355.36M |
| June 30, 2018 | 386.89M |
| March 31, 2018 | 326.08M |
| December 31, 2017 | 373.88M |
| September 30, 2017 | 241.84M |
| June 30, 2017 | 274.85M |
| March 31, 2017 | 274.72M |
| December 31, 2016 | 311.26M |
| September 30, 2016 | 339.86M |
| June 30, 2016 | 368.85M |
| March 31, 2016 | 325.66M |
| December 31, 2015 | 359.27M |
| September 30, 2015 | 384.09M |
| June 30, 2015 | 254.20M |
| March 31, 2015 | 278.07M |
| December 31, 2014 | 173.89M |
| September 30, 2014 | 193.62M |
| June 30, 2014 | 205.72M |
| March 31, 2014 | 210.17M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AbbVie, Inc. | 135.12B |
| Gilead Sciences, Inc. | 49.36B |
| Xencor, Inc. | 724.96M |
| Akari Therapeutics Plc | 38.62M |
| Janux Therapeutics, Inc. | 1.008B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 302.54M |
| Shareholders Equity (Quarterly) | 42.87M |
| Debt to Equity Ratio | 4.624 |
| Current Ratio | 2.956 |
| Net Debt Paydown Yield | -10.94% |